Boston Scientific Corporation
Boston Scientific (NYSE: BSX) is a worldwide developer, manufacturer and marketer of medical devices with approximately 24,000 employees and revenue of $7.25 billion in 2012. For more than 30 years, Boston Scientific has advanced the practice of less-invasive medicine by providing a broad and deep portfolio of innovative products, technologies and services across a wide range of medical specialties. The Company's products help physicians and other medical professionals improve their patients' quality of life by providing alternatives to surgery. For more information, please visit www.bostonscientific.com.
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
Boston Scientific's history began in the late 1960s, when co-founder John Abele acquired an equity interest in Medi-tech, Inc., a research and development company focused on developing alternatives to traditional surgery. Medi-tech's first products, a family of steerable catheters, were introduced in 1969 and were used in some of the first less-invasive procedures. Versions of these steerable catheters are still used today. In 1979, Abele and Pete Nicholas partnered to buy Medi-tech and together formed Boston Scientific Corporation.
2012 Revenue: $7.249 billion
Stock Exchange: NYSE, Symbol: BSX
One Boston Scientific Place
Natick, MA 01760-1537
Singapore and Paris, France
Boston Scientific's 2010 Annual Report is available to download by CLICKING HERE.